Strides Pharma Science shares jump 9% after USFDA EIR for Bengaluru facility
· economictimes.indiatimes.com
Strides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru facility, concluding a recent cGMP inspection. The inspection ended with five observations, which the company addressed through corrective actions. The regulatory closure offers relief after the stocks recent weakness.
Live Events
Stock Performance and Valuation
Technical Indicators
as a Reliable and Trusted News Source Addas a Reliable and Trusted News Source Add Now!
(...